Marco Valgimigli
Declaration of interest
| Function | Company |
|---|---|
| Honorarium | Abbott Diagnostic |
| Honorarium | Abbott Vascular |
| Honorarium | Astrazeneca |
| Honorarium | CID |
| Honorarium | Daiichi Sankyo Europe |
| Honorarium | Eli Lilly |
| Honorarium | Iroko |
| Honorarium | Merck |
| Honorarium | St Jude Medical |
| Honorarium | Terumo |
| Honorarium | The Medicines Company |
Latest contributions
Large thrombus burden management in a young patient with inferior STEMI and multivessel disease
08 Oct 2025
A 51-year-old man with an inferior STEMI and multivessel disease was found to have a thrombotic sub-occlusion in the mid RCA. Angiography also revealed significant disease in the LAD. How would you manage this case?
Author
Author
Author
Pharmacotherapy coronary interventions: new insights
22 May 2025 – From EuroPCR 2025
Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...
Pushing boundaries in complex PCIs: unique DES technology for complex lesions and patients
21 May 2025 – From EuroPCR 2025
Explore cutting-edge strategies in complex PCI through four detailed clinical cases: a challenging left main bifurcation, a complex procedure using Guideliner Extension Catheters (GEC), an acute coronary syndrome intervention, and treatment of a patient with high bleeding and ischemic risks. This session demonstrates how thorough patient...
Antithrombotic drugs for acute coronary syndromes in women
21 May 2025 – From EuroPCR 2025
Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...
Novelty in no-reflow management in STEMI patients
20 May 2025 – From EuroPCR 2025
Discover novel approaches to manage no-reflow phenomenon in STEMI patients. This session covers innovative therapies including the OPTI-STEMI trial strategies, mechanical thrombectomy, pharmacological interventions with Cangrelor, and super saturated oxygen therapy targeting coronary microcirculation preservation.
Is this patient a good candidate for Left Atrial Appendage Closure? An interactive rapid-fire discussion
16 May 2024 – From EuroPCR 2024
This interactive session focuses on selecting good candidates for left atrial appendage (LAA) closure procedures. It covers the key clinical elements driving the indication for LAA closure and the technical elements that make a case complex. Through a series of case presentations and discussions, the session...
Antiplatelet de-escalation after complex PCI: when and how?
15 May 2024 – From EuroPCR 2024
From innovation to reality: the impact of Cre8 EVO technology on complex PCI
15 May 2024 – From EuroPCR 2024
This session is a good opportunity to delve into the contemporary technical and clinical complexities surrounding complex PCIs in challenging patient cases. Explore the necessary tools and treatment strategies to enhance peri-procedural and long-term clinical outcomes, and follow discussions on the unique technologies of Cre8 EVO...
EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)
19 May 2023 – From EuroPCR 2023
What are the most significant facts in this respect? Get the essentials by listening to the presenters review some clinical hotlines. To cite a few, Selective Intracoronary hypothermia in anterior wall myocardial infarction; real-time catheter-based microvascular obstruction detection in STEMI : results from the MOCCA I...
Managing high-bleeding risk in case examples
18 May 2023 – From EuroPCR 2023
In these slides, discover techniques to assess bleeding and thrombotic risk in PCI patients, explore antithrombotic options, and implement strategies for risk minimisation.
Percutaneous LAA closure 2.0
17 May 2023 – From EuroPCR 2023
In these slides, delve into advanced Percutaneous LAA Closure 2.0. Optimise procedure planning, grasp key post-procedural follow-up aspects, master essential tips for WatchmanFLX and Amulet device implantation, and much more.
Making treatment and management of complex PCIs easier with Cre8 EVO
17 May 2023 – From EuroPCR 2023
Maximize patient clinical outcomes in complex percutaneous coronary interventions (PCIs) by joining this session. Discover how accurate patient evaluation, advanced imaging/functional modalities, optimized procedures, and the Cre8 EVO device contribute to improved safety and efficacy, and review the challenges associated with DES implantation in complex PCIs.
Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform
16 May 2023 – From EuroPCR 2023
What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...
The CorFlow MOCA I Trial: learnings from the first-in-human direct measurement of microvascular obstruction in STEMI
16 May 2023 – From EuroPCR 2023
To help you better understand the MOCA I Late-Breaking clinical Trial and its findings, follow this exchange between Rob Schwartz, Marco Valgimigli, and Azeem Latib.
What is this study about? What technology are we talking about exactly? Why is it important for clinical practice? How can we...
Nightmares during primary PCI: large thrombus burden management in an ectatic Left anterior Descending Coronary Artery
08 Dec 2022
A 61-year-old man was admitted to the catheterization laboratory for anterior STEMI. Coronary angiography revealed a large thrombus burden in an ectatic and occluded LAD. How would you treat this challenging case?
Author
Author
Author
Author
How should I treat a patient at high bleeding risk requiring complex PCI?
05 Nov 2020
Discover the replay of this webinar on high bleeding risk and complex PCI, with T. Cuisset, P. Smits and M. Valgimigli.
PCR Innovators Day - Competition for the Jon DeHaan Award
19 May 2022 – From EuroPCR 2022
Best-graded contributions for the Innovators Day were considered for this competition. Among them, find out more about transcatheter calcium modifying treatment of the stenotic aortic valve, capture technology for treating mitral regurgitation, or transcatheter microwave renal denervation guided by aorticorenal ganglion pacing.
The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI
19 May 2022 – From EuroPCR 2022
Consult this session to learn more about the characteristics of atrial fibrillation patients undergoing TAVI, the priority of stroke prevention in atrial fibrillation patients post-TAVI, as well as the current understanding in Japanese and Asian patients.
The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...
Cre8 EVO: the "sweetest advancement" that a diabetic patient is waiting for
18 May 2022 – From EuroPCR 2022
Thanks to a mix between cases and live lectures and discussions, this EuroPCR 2022 session will enable you to review the challenges of a PCI and the one-year results of the SUGAR RCT in diabetes mellitus patients, and to understand how to maximise PCI outcomes, especially by using Cre8 EVO...
Antithrombotics in practice after PCI: from evidence to individual patient management
17 May 2022 – From EuroPCR 2022
In this session, compare the case of a typical ACS PCI patient with two cases with chronic settings to see whether there are other options to be considered as far as antithrombotic strategy is concerned.
NSTEMI PCI: LIVE case from St Thomas' Hospital - London, United Kingdom
17 May 2022 – From EuroPCR 2022
Watch the case of a 65-year-old ex-smoker, male patient, with hypertension and cholesterol, who presented with chest pain at rest, symptomatic with nausea and dizziness, and find out how this NSTE-ACE patient was treated.
Celebrating 30 years of transradial artery access!
17 May 2022
Thirty years ago, the interventional cardiology field was transformed with the emergence of a new access site – the radial artery was used for coronary angioplasty and stent implantation for the first time on 14 August 1992.
Author
Author
What is the best antithrombotics strategy after PCI? - EuroPCR 2022
17 May 2022
Case-based discussions and the very first presentation of data from two meta-analyses combine in an interactive session that aims to help clinicians navigate their way through the use of acute and chronic antithrombotics.
Author
MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients - interview with Marco Valgimigli
28 Aug 2021
ESC Congress 2021: Discover the interview given by Marco Valgimigli to Luis G. Ortega-Paz for PCRonline about the MASTER-DAPT trial to assess whether one month of dual antiplatelet therapy preserves the net and major adverse cardiovascular events.
Author
Author
Empowering DES performance in complex patients to maximise efficacy and safety outcomes
20 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...
Short DAPT in high bleeding risk: ready for prime time?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...
Challenges and opportunities in high-risk patients undergoing TAVI
19 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation
What you need to know about DAPT in high-bleeding risk patients
12 Dec 2020 – From GulfPCR-GIM 2020
This educational session focuses on the high-bleeding risk situation in the Gulf Region, the latest evidence on HBR and how to integrate it into your practice, followed by challenging cases discussed by Mirvat Alasnag,Thomas Cuisset, Marco Valgimigli and Peter Smits.
